Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (291-300 of 455) with videos related to

Pageof 46
Sort By:
European Journal of Endocrinology|May 23, 2024
Increased hepatic glucagon sensitivity in totally pancreatectomised patientsIben Rix, Asger B Lund, Lars F Garvey, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2011
2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humansKatrine B Hansen, Mette M Rosenkilde, Filip K Knop, et al.
Diabetes Care|July 15, 2020
Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)Alexander S Christensen, Sofie Hædersdal, Julie Støy, et al.
European Journal of Endocrinology|May 25, 2013
Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplastyAstrid Plamboeck, Simon Veedfald, Carolyn F Deacon, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 20, 2013
The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplastyAstrid Plamboeck, Simon Veedfald, Carolyn F Deacon, et al.
Diabetes Care|August 19, 2015
Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized TrialThomas Idorn, Filip K Knop, Morten B Jørgensen, et al.
Communications Biology|March 27, 2021
INPP4B protects from metabolic syndrome and associated disordersManqi Zhang, Yasemin Ceyhan, Elena M Kaftanovskaya, et al.
Diabetes, Obesity & Metabolism|May 19, 2023
Glycaemia and cardiac arrhythmias in people with type 1 diabetes: A prospective observational studyPer G Hagelqvist, Andreas Andersen, Kaisar Maytham, et al.
Clinical and Translational Gastroenterology|November 27, 2024
Liraglutide and Colesevelam Change Serum and Fecal Bile Acid Levels in a Randomized Trial With Patients With Bile Acid DiarrheaAnne-Marie Ellegaard, Martin L Kårhus, Lukasz Krych, et al.
The Journal of Clinical Endocrinology and Metabolism|July 19, 2023
Signs of a Glucose- and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 DiabetesBolette Hartmann, Miriam Longo, David S Mathiesen, et al.
Pageof 46

Showing results (291-300 of 455) with videos related to

Sort By:
Pageof 46
European Journal of Endocrinology|May 23, 2024
Increased hepatic glucagon sensitivity in totally pancreatectomised patientsIben Rix, Asger B Lund, Lars F Garvey, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2011
2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humansKatrine B Hansen, Mette M Rosenkilde, Filip K Knop, et al.
Diabetes Care|July 15, 2020
Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)Alexander S Christensen, Sofie Hædersdal, Julie Støy, et al.
European Journal of Endocrinology|May 25, 2013
Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplastyAstrid Plamboeck, Simon Veedfald, Carolyn F Deacon, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 20, 2013
The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplastyAstrid Plamboeck, Simon Veedfald, Carolyn F Deacon, et al.
Diabetes Care|August 19, 2015
Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized TrialThomas Idorn, Filip K Knop, Morten B Jørgensen, et al.
Communications Biology|March 27, 2021
INPP4B protects from metabolic syndrome and associated disordersManqi Zhang, Yasemin Ceyhan, Elena M Kaftanovskaya, et al.
Diabetes, Obesity & Metabolism|May 19, 2023
Glycaemia and cardiac arrhythmias in people with type 1 diabetes: A prospective observational studyPer G Hagelqvist, Andreas Andersen, Kaisar Maytham, et al.
Clinical and Translational Gastroenterology|November 27, 2024
Liraglutide and Colesevelam Change Serum and Fecal Bile Acid Levels in a Randomized Trial With Patients With Bile Acid DiarrheaAnne-Marie Ellegaard, Martin L Kårhus, Lukasz Krych, et al.
The Journal of Clinical Endocrinology and Metabolism|July 19, 2023
Signs of a Glucose- and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 DiabetesBolette Hartmann, Miriam Longo, David S Mathiesen, et al.
Pageof 46